Trials / Completed
CompletedNCT05359094
Probiotic Supplements in Chronic Kidney Disease
To Explore the Effect of Probiotic Supplements in Chronic Kidney Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Taichung Veterans General Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This research will investigate the effect of oral probiotic supplements on renal function, uremic toxins inflammatory response, nutrition status, gastrointestinal symptoms, and QoL with Chronic kidney disease.
Detailed description
Chronic kidney disease (CKD) with gut microbiota was different from a normal person. Some gut microbiota produces short-chain fatty acids or induces functional enzymes beneficial to patients. On the other hand, some gut microbiota may also metabolize amino acids into p-cresol and indole which were leading to the accumulation of urinary toxins and damage to the kidney. This research will investigate the effect of oral probiotic supplements on renal function, uremic toxins, inflammatory response, nutrition status, gastrointestinal symptoms, and QoL with CKD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | Placebo (Microcrystalline α-cellulose) supplement with a Plant-Dominant Low-Protein Diet |
| DIETARY_SUPPLEMENT | Probiotics | Probiotics(Pediococcus acidilactici GKA4) supplement with a Plant-Dominant Low-Protein Diet |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2023-08-08
- Completion
- 2024-07-15
- First posted
- 2022-05-03
- Last updated
- 2024-07-23
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05359094. Inclusion in this directory is not an endorsement.